MeiraGTx Holdings (MGTX) EBITDA Margin (2019 - 2025)
MeiraGTx Holdings (MGTX) reported EBITDA Margin of 31.59% for Q4 2025, up 21050.0% on a YoY basis from N/an in Q4 2024, and up 100.26% quarter-over-quarter from 12024.39% in Q3 2025.
MeiraGTx Holdings (MGTX) EBITDA Margin (2019 - 2025) Analysis & Trends
MeiraGTx Holdings has reported EBITDA Margin for 7 years, with the latest figure at 31.59% in Q4 2025.
- For the quarter ending Q4 2025, EBITDA Margin rose 21050.0% year-over-year to 31.59%; the trailing twelve-month figure through Dec 2025 stood at 107.16% (up 34380.0% YoY), and the FY2025 full-year result was 132.79%, up 31817.0% from the prior year.
- EBITDA Margin for Q4 2025 stood at 31.59%, up from 12024.39% in the prior quarter.
- The five-year high for EBITDA Margin was 693.21% in Q4 2022, with the low at 17414.18% in Q2 2024.
- Historically, EBITDA Margin has averaged 2014.99% across 5 years, with a median of 516.83% in 2022.
- Annual changes were most pronounced in 2024 — EBITDA Margin slumped 1650678 bps — and 2025, when it jumped 1629649 bps.
- MeiraGTx Holdings' EBITDA Margin stood at 45.99% in 2021, then jumped by 1607 bps to 693.21% in 2022, then decreased by 18 bps to 569.61% in 2023, then slumped by 131 bps to 178.92% in 2024, then surged by 118 bps to 31.59% in 2025.
- The last three EBITDA Margin figures came in at 31.59% (Q4 2025), 12024.39% (Q3 2025), and 1117.69% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 31.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 31.59% |
| Sep 30, 2025 | -12,024.39% |
| Jun 30, 2025 | -1,117.69% |
| Dec 31, 2024 | -178.92% |
| Sep 30, 2024 | -371.81% |
| Jun 30, 2024 | -17,414.18% |
| Mar 31, 2024 | -3,175.47% |
| Dec 31, 2023 | 569.61% |
| Sep 30, 2023 | -750.34% |
| Jun 30, 2023 | -907.40% |
| Mar 31, 2023 | -981.31% |
| Dec 31, 2022 | 693.21% |
| Sep 30, 2022 | -592.03% |
| Jun 30, 2022 | -247.38% |
| Mar 31, 2022 | -516.83% |
| Dec 31, 2021 | -45.99% |
| Sep 30, 2021 | -335.00% |
| Jun 30, 2021 | -400.57% |
| Mar 31, 2021 | -519.87% |
| Dec 31, 2020 | -367.11% |